Joliat MJ - Search Results

1

The molecular bases of spontaneous immunological mutations in the mouse and their homologous human diseases.

Joliat MJ, Shultz LD. Joliat MJ, et al. Clin Immunol. 2001 Nov;101(2):113-29. doi: 10.1006/clim.2001.5120. Clin Immunol. 2001. PMID: 11683570 Review. No abstract available.

2

Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.

Joliat MJ, Lang PA, Lyons BL, Burzenski L, Lynes MA, Yi T, Sundberg JP, Shultz LD. Joliat MJ, et al. J Autoimmun. 2002 Mar;18(2):105-17. doi: 10.1006/jaut.2001.0570. J Autoimmun. 2002. PMID: 11908943

3

T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.

Christianson SW, Greiner DL, Deluca D, Leif J, Phillips NE, Hayes SM, Hayashi S, Joliat MJ, Lyons BL, Shultz LD. Christianson SW, et al. Among authors: joliat mj. J Autoimmun. 2002 Mar;18(2):119-30. doi: 10.1006/jaut.2001.0571. J Autoimmun. 2002. PMID: 11908944

4

Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma.

Joliat MJ, Umeda S, Lyons BL, Lynes MA, Shultz LD. Joliat MJ, et al. In Vivo. 2002 Jul-Aug;16(4):223-8. In Vivo. 2002. PMID: 12224130

5

Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice.

Lyons BL, Lynes MA, Burzenski L, Joliat MJ, Hadjout N, Shultz LD. Lyons BL, et al. Among authors: joliat mj. Exp Hematol. 2003 Mar;31(3):234-43. doi: 10.1016/s0301-472x(02)01031-7. Exp Hematol. 2003. PMID: 12644021 Free article.

6

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.

Nilsson M, Joliat MJ, Miner CM, Brown EB, Heiligenstein JH. Nilsson M, et al. Among authors: joliat mj. J Child Adolesc Psychopharmacol. 2004 Fall;14(3):412-7. doi: 10.1089/cap.2004.14.412. J Child Adolesc Psychopharmacol. 2004. PMID: 15650497 Clinical Trial.

7

Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.

Joliat MJ, Brown EB, Miner CM. Joliat MJ, et al. J Clin Psychopharmacol. 2004 Aug;24(4):464-7. doi: 10.1097/01.jcp.0000132345.35713.16. J Clin Psychopharmacol. 2004. PMID: 15232349 No abstract available.

8

Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.

Joliat MJ, Schmidt ME, Fava M, Zhang S, Michelson D, Trapp NJ, Miner CM. Joliat MJ, et al. J Clin Psychiatry. 2004 Mar;65(3):373-8. doi: 10.4088/jcp.v65n0313. J Clin Psychiatry. 2004. PMID: 15096077 Clinical Trial.

9

Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.

Chalon SA, Granier LA, Vandenhende FR, Bieck PR, Bymaster FP, Joliat MJ, Hirth C, Potter WZ. Chalon SA, et al. Among authors: joliat mj. Neuropsychopharmacology. 2003 Sep;28(9):1685-93. doi: 10.1038/sj.npp.1300209. Epub 2003 May 28. Neuropsychopharmacology. 2003. PMID: 12784100 Clinical Trial.

10

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.

Pearlstein T, Joliat MJ, Brown EB, Miner CM. Pearlstein T, et al. Among authors: joliat mj. Am J Obstet Gynecol. 2003 Apr;188(4):887-95. doi: 10.1067/mob.2003.207. Am J Obstet Gynecol. 2003. PMID: 12712081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters